Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Neurology. 2024 May 14;102(9):e209375. doi: 10.1212/WNL.0000000000209375. Epub 2024 Apr 22.

Authors

Paolo Salvioni Chiabotti¹, Olivier Rouaud¹, Gilles Allali¹

Affiliation

¹ (Lausanne, Switzerland).

PMID: 38648577
DOI: 10.1212/WNL.0000000000209375

No abstract available

Publication types

Letter

MeSH terms

Aged
Alzheimer Disease / drug therapy
Amyloid beta-Peptides
Cognitive Aging* / physiology
Humans

Substances

Amyloid beta-Peptides